References
1. United Nations Inter-agency Group for Child Mortality Estimation (UNIGME). Levels & Trends in Child Mortality: Report 2022, Estimates developed by the United Nations Inter-agency Group for Child Mortality Estimation. New York; 2023.
2. Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL, et al. Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the Sustainable Development Goals. The Lancet Child & adolescent health. 2022;6(2):106-15.
3. Katz J, Lee AC, Kozuki N, Lawn JE, Cousens S, Blencowe H, et al. Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysis. Lancet. 2013;382(9890):417-25.
4. Wynn A, Bristow CC, Cristillo AD, Murphy SM, van den Broek N, Muzny C, et al. Sexually Transmitted Infections in Pregnancy and Reproductive Health: Proceedings of the STAR Sexually Transmitted Infection Clinical Trial Group Programmatic Meeting. Sex Transm Dis. 2019.
5. Grant JS, Chico RM, Lee AC, Low N, Medina-Marino A, Molina RL, et al. Sexually Transmitted Infections in Pregnancy: A Narrative Review of the Global Research Gaps, Challenges, and Opportunities. Sex Transm Dis. 2020;47(12):779-89.
6. Silva M, Florencio G, Gabiatti J, Amaral R, Eleuterio J, Goncalves A. Perinatal morbidity and mortality associated with chlamydial infection: a meta-analysis study. The Brazilian journal of infectious diseases. 2011;15(6):533-9.
7. Vallely LM, Egli-Gany D, Wand H, Pomat WS, Homer CSE, Guy R, et al. Adverse pregnancy and neonatal outcomes associated with Neisseria gonorrhoeae: systematic review and meta-analysis. Sex Transm Infect. 2021;97(2):104-11.
8. Adachi KN, Nielsen-Saines K, Klausner JD. Chlamydia trachomatis Screening and Treatment in Pregnancy to Reduce Adverse Pregnancy and Neonatal Outcomes: A Review. Front Public Health. 2021;9:531073.
9. Medline A, Joseph Davey D, Klausner JD. Lost opportunity to save newborn lives: variable national antenatal screening policies for Neisseria gonorrhoeae and Chlamydia trachomatis. International Journal of STD & AIDS. 2016;28(7):660-6.
10. Romoren M, Sundby J, Velauthapillai M, Rahman M, Klouman E, Hjortdahl P. Chlamydia and gonorrhoea in pregnant Batswana women: time to discard the syndromic approach? BMC infectious diseases. 2007;7(27):Published online.
11. Wynn A, Mussa A, Ryan R, Hansman E, Simon S, Bame B, et al. Evaluating the diagnosis and treatment of Chlamydia trachomatis and Neisseria gonorrhoeae in pregnant women to prevent adverse neonatal consequences in Gaborone, Botswana: protocol for the Maduo study. BMC infectious diseases. 2022;22(1):229.
12. Centers for Disease Control and Prevention. Sexually Transmitted Infections Treatment Guidelines, 2021. 2021.
13. Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
14. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75-84.
15. Institute of Medicine Committee on Improving Birth Outcomes. The Problem of Low Birth Weight. In: Bale J, Stoll B, Lucas A, editors. Improving Birth Outcomes: Meeting the Challenge in the Developing World Washington (DC: National Academies Press; 2003.
16. World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. Guideline. 2016.
17. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Archives of internal medicine. 1998;158(16):1789-95.
18. Wooldridge J. Introductory Econometrics: A Modern Approach. 4th ed: South-Western; 2009.
19. Muller CJ, MacLehose RF. Estimating predicted probabilities from logistic regression: different methods correspond to different target populations. International journal of epidemiology. 2014;43(3):962-70.
20. Tang W, Mao J, Li KT, Walker JS, Chou R, Fu R, et al. Pregnancy and fertility-related adverse outcomes associated with Chlamydia trachomatis infection: a global systematic review and meta-analysis. Sex Transm Infect. 2020;96(5):322-9.
21. World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually
transmitted infections for the period 2022-2030. Geneva.; 2022. Contract No.: CC BY-NC-SA 3.0 IGO.
22. Bretelle F, Loubière S, Desbriere R, Loundou A, Blanc J, Heckenroth H, et al. Effectiveness and Costs of Molecular Screening and Treatment for Bacterial Vaginosis to Prevent Preterm Birth: The AuTop Randomized Clinical Trial. JAMA pediatrics. 2023.
23. Batteiger BE, Xu F, Johnson RE, Rekart ML. Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies. J Infect Dis. 2010;201 Suppl 2(S2):S178-89.
24. Ryan G AT, McNeeley S, Baselski V, Drummond D. Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome. American Journal of Obstetrics & Gynecology. 1990;162(1):34-9.
25. Martin DH, Eschenbach DA, Cotch MF, Nugent RP, Rao AV, Klebanoff MA, et al. Double-Blind Placebo-Controlled Treatment Trial of Chlamydia trachomatis Endocervical Infections in Pregnant Women. Infect Dis Obstet Gynecol. 1997;5(1):10-7.
26. Cohen I VJ, Calkins BM. Improved pregnancy outcome following successful treatment of chlamydial infection. JAMA. 1990;263(23):3160-3.
27. Rastogi S DB, Salhan S, Mittal A. Effect of treatment for Chlamydia trachomatis during pregnancy. Int J Gynaecol Obstet. 2003;80(2):129-37.
28. McGregor JA, French JI, Richter R, Vuchetich M, Bachus V, Seo K, et al. Cervicovaginal microflora and pregnancy outcome: results of a double-blind, placebo-controlled trial of erythromycin treatment. Am J Obstet Gynecol. 1990;163(5 Pt 1):1580-91.
29. Peters R, Klausner J, Feucht U, Vos L, Medina-Marino A. Aetiologic testing compared with syndromic management for sexually transmitted infections in HIV-infected pregnant women in South Africa: a non-randomised prospective cohort study. BJOG An International Journal of Obstetrics & Gynaecology. 2020.
30. Medina-Marino A, Mudau M, Kojima N, Peters RP, Feucht UD, Vos L, et al. Persistent Chlamydia trachomatis, Neisseria gonorrhoeae or Trichomonas vaginalis positivity after treatment among human immunodeficiency virus-infected pregnant women, South Africa. Int J STD AIDS. 2020;31(4):294-302.
31. Mussa A, Wynn A, Ryan R, Babalola C, Simon S, Ramontshonyana K, et al. High Cure Rate Among Pregnant Women in a Chlamydia trachomatis and Neisseria gonorrhoeae Testing and Treatment Intervention Study in Gaborone, Botswana. Sex Transm Dis. 2023;50(2):124-7.
32. Low N. Chlamydia trachomatis and reproductive health: what can we learn from systematic reviews of observational studies? Sex Transm Infect. 2020;96(5):315-7.
33. Vallely AJ, Pomat WS, Homer C, Guy R, Luchters S, Mola GDL, et al. Point-of-care testing and treatment of sexually transmitted infections to improve birth outcomes in high-burden, low-income settings: Study protocol for a cluster randomized crossover trial (the WANTAIM Trial, Papua New Guinea). Wellcome open research. 2019;4:53.
34. Torgerson DJ. Contamination in trials: is cluster randomisation the answer? Bmj. 2001;322(7282):355-7.